The following table presents information regarding certain components of income (loss) from discontinued operations in the condensed consolidated statements of operations (in thousands): | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | | | June 30, | | June 30, | | | | 2026 | | 2025 | | 2026 | | 2025 | | Life Sciences Services revenue | | $ | — | | $ | 15,068 | | $ | — | | $ | 32,161 | | Cost of services revenue | | | — | | | (8,596) | | | — | | | (20,992) | | Selling, general and administrative | | | — | | | (5,412) | | | — | | | (15,250) | | Gain (loss) on disposal | | | — | | | 120,351 | | | (1,112) | | | 120,351 | | Other expense | | | — | | | (400) | | | — | | | (391) | | Pretax income (loss) from discontinued operations | | | — | | | 121,011 | | | (1,112) | | | 115,879 | | Provision for income taxes | | | — | | | (128) | | | — | | | (239) | | Income (loss) from discontinued operations, net | | $ | — | | $ | 120,883 | | $ | (1,112) | | $ | 115,640 | |
The following table presents depreciation and amortization, capital expenditures and significant operating and investing noncash items from discontinued operations for the six months ended June 30, 2026 and 2025 included within the condensed consolidated statements of cash flows (in thousands): | | | | | | | | | | Six Months Ended | | | | June 30, | | | | 2026 | | 2025 | | Operating activities: | | | | | | | | Depreciation and amortization | | $ | — | | $ | 2,559 | | Stock-based compensation expense | | | — | | | 966 | | Non-cash operating lease expense | | | — | | | 1,316 | | Investing activities: | | | | | | | | Purchases of property and equipment | | $ | — | | $ | 2,407 | | Software development costs | | | — | | | 1,142 | |
|